COVID-19 Vaccination and Glomerulonephritis - ScienceDirect
Convergent antibody evolution and clonotype expansion following influenza virus vaccination | PLOS ONE
Vaccines | Free Full-Text | Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022? — JOGH
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
University Health Services to Have Flu Vaccine Clinics in October
Frontiers | Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus - ScienceDirect
Beckman Coulter · Diazyme Human Kappa & Lambda FLC assays • healthcare-in-europe.com
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines | Nature Communications
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
